GetTopicDetailResponse(id=63e8109365fb, topicName=LINE-1, introduction=LINE-1, content=null, image=null, comments=0, allHits=819, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Thu Dec 28 17:08:12 CST 2023, time=2023-12-28, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=462922, tagList=[TagDto(tagId=462922, tagName=LINE-1)], ipAttribution=浙江省, topicAdmin=0, lengthMark=null)
[GetTopicListResponse(id=2189394, encodeId=7342218939499, content=<a href='/topic/show?id=63e8109365fb' target=_blank style='color:#2F92EE;'>#LINE-1#</a> <a href='/topic/show?id=877011155123' target=_blank style='color:#2F92EE;'>#逆轉(zhuǎn)錄轉(zhuǎn)座子#</a> <a href='/topic/show?id=880d152006a' target=_blank style='color:#2F92EE;'>#rDNA#</a> <a href='/topic/show?id=92e91468174' target=_blank style='color:#2F92EE;'>#Print#</a>, objectTitle=Nat Biotechnol：利用真核逆轉(zhuǎn)錄因子蛋白將轉(zhuǎn)基因插入人類安全港位點(diǎn)，有望開發(fā)出安全高效的基因療法, objectType=article, longId=814761, objectId=f116814e61e8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240225/1708859213362_2185383.png, objectUrl=/article/show_article.do?id=f116814e61e8, replyNumber=0, likeNumber=0, createdTime=2024-02-26, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2177829, encodeId=a17a21e782989, content=<a href='/topic/show?id=63e8109365fb' target=_blank style='color:#2F92EE;'>#LINE-1#</a> <a href='/topic/show?id=1e291093661f' target=_blank style='color:#2F92EE;'>#逆轉(zhuǎn)錄酶#</a> <a href='/topic/show?id=00ba10936e4d' target=_blank style='color:#2F92EE;'>#黑暗基因組#</a>, objectTitle=Nature：揭示人類LINE-1 ORF2蛋白的結(jié)構(gòu)、功能和適應(yīng)性, objectType=article, longId=805499, objectId=a3258054995c, topicUrl=null, isHasObj=0, objectCover=https://msimg.bioon.com/bioon-com/20231217/1702770645098_2185383.png, objectUrl=/article/show_article.do?id=a3258054995c, replyNumber=0, likeNumber=80, createdTime=2023-12-28, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=浙江省, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2023-12-28發(fā)表于浙江省
